These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15939214)

  • 1. A review on the design and reporting of studies on drug-gene interaction.
    Smits KM; Schouten JS; Smits LJ; Stelma FF; Nelemans P; Prins MH
    J Clin Epidemiol; 2005 Jul; 58(7):651-4. PubMed ID: 15939214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL; Williamson PR
    Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodologic ramifications of paying attention to sex and gender differences in clinical research.
    Prins MH; Smits KM; Smits LJ
    Gend Med; 2007; 4 Suppl B():S106-10. PubMed ID: 18156096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature.
    Scales CD; Norris RD; Keitz SA; Peterson BL; Preminger GM; Vieweg J; Dahm P
    J Urol; 2007 Mar; 177(3):1090-4; discussion 1094-5. PubMed ID: 17296417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 4: observational studies.
    Manchikanti L; Singh V; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(1):73-108. PubMed ID: 19165298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial design issues: at least 10 things you should look for in clinical trials.
    Glasser SP; Howard G
    J Clin Pharmacol; 2006 Oct; 46(10):1106-15. PubMed ID: 16988199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Roaming through methodology. XXIV. Problems in generalizing from randomized intervention studies with selected patient populations].
    Zielhuis GA
    Ned Tijdschr Geneeskd; 2000 Sep; 144(39):1860-4. PubMed ID: 11031678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews.
    Hayden JA; Chou R; Hogg-Johnson S; Bombardier C
    J Clin Epidemiol; 2009 Aug; 62(8):781-796.e1. PubMed ID: 19136234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic studies in depression: a proposal for methodologic guidelines.
    Serretti A; Kato M; Kennedy JL
    Pharmacogenomics J; 2008 Apr; 8(2):90-100. PubMed ID: 17684474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic reviews involving complementary and alternative medicine interventions had higher quality of reporting than conventional medicine reviews.
    Lawson ML; Pham B; Klassen TP; Moher D
    J Clin Epidemiol; 2005 Aug; 58(8):777-84. PubMed ID: 16018912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect.
    Kyzas PA; Denaxa-Kyza D; Ioannidis JP
    J Natl Cancer Inst; 2007 Feb; 99(3):236-43. PubMed ID: 17284718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgeon equipoise as an inclusion criterion for the evaluation of nonoperative versus operative treatment of thoracolumbar spinal injuries.
    Stadhouder A; Oner FC; Wilson KW; Vaccaro AR; Williamson OD; Verbout AJ; Verhaar JA; de Klerk LW; Buskens E
    Spine J; 2008; 8(6):975-81. PubMed ID: 18261964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of reporting of randomized, controlled trials in cerebral palsy.
    Anttila H; Malmivaara A; Kunz R; Autti-Rämö I; Mäkelä M
    Pediatrics; 2006 Jun; 117(6):2222-30. PubMed ID: 16740868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trial design--towards better practices.
    Correia O; Faergemann J; Nowicki R; Ro BI
    J Eur Acad Dermatol Venereol; 2005 Sep; 19 Suppl 1():40-2. PubMed ID: 16120205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does a "Level I Evidence" rating imply high quality of reporting in orthopaedic randomised controlled trials?
    Poolman RW; Struijs PA; Krips R; Sierevelt IN; Lutz KH; Bhandari M
    BMC Med Res Methodol; 2006 Sep; 6():44. PubMed ID: 16965628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.